A phase I study of CKD-702, an EGFR-cMET bispecific antibody, in advanced or metastatic non-small cell lung cancer (NSCLC)

被引：1
|
作者：
Kim, D-W. [1 ,2 ]
Lee, S-H. [3 ]
Jang, I-J. [4 ]
Park, K-J. [5 ]
Lee, D. H. [6 ]
机构：
[1] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[2] Seoul Natl Univ Hosp, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea
[4] Seoul Univ Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South Korea
[5] CKD Chong Kun Dang Res Inst Hyojong, Bio Drug Discovery, Yongin, South Korea
[6] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1124
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
998P
引用
收藏
页码：S1010 / S1010
页数：1
相关论文
共 50 条
  • [41] Paclitaxel and carboplatin: A phase I study in advanced non-small cell lung cancer
    Paccagnella, A
    Favaretto, A
    Oniga, F
    Ossana, L
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 76 - 79
  • [42] A PHASE I STUDY OF THE ANTI-EGFR ANTIBODY NIMOTUZUMAB COMBINED WITH PALLIATIVE THORACIC RADIATION FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Brade, A.
    Bebb, G.
    Smith, C.
    Rorke, S.
    Sherman, I.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S6 - S6
  • [43] Phase IV Study of Afatinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Thongprasert, Sumitra
    Boldeanu, Cosmin
    Radosavljevic, Davorin
    Petrovic, Marina
    Jones, Hilary
    Cseh, Agnieszka
    Gaafar, Rabab
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S667 - S667
  • [44] Comorbidity in clinical trial patients with advanced or metastatic non-small cell lung cancer (NSCLC).
    Kosov, Maxim
    Kumar, Akhil
    Belotserkovskiy, Maxim
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [45] Palliative thoracic radiotherapy in locally advanced/metastatic non-small cell lung cancer (NSCLC)
    Maclennan, K.
    Campbell, S.
    Little, F.
    Erridge, S.
    Evans, T.
    Price, A.
    LUNG CANCER, 2016, 91 : S53 - S54
  • [46] Sunitinib in Combination with Erlotinib for the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Thongprasert, Sumitra
    Govindan, Ramaswamy
    Krzakowski, Maciej
    Szczesna, Aleksandra
    Strausz, Janos
    Makhson, Anatoly
    Tye, Lesley
    Zhang, Ke
    Chao, Richard C.
    Scagliotti, Giorgio V.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S375 - S375
  • [47] Gemcitabine plus cisplatin in advanced non-small cell lung cancer (NSCLC): A phase II study
    Orlandi-Jorquera, L
    Orlandi, F
    Galaz, P
    Gamargo, C
    Salman, P
    Yanez, M
    ANNALS OF ONCOLOGY, 1998, 9 : 101 - 101
  • [48] Phase II study of nivolumab in patients with advanced non-small cell lung cancer (NSCLC) in Korea
    Cho, E. K.
    Kang, J. H.
    Han, J-Y.
    Lee, J. S.
    Kim, D-W.
    Kim, S-W.
    Min, Y. J.
    Lee, K. H.
    Kim, J-H.
    Park, K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [49] Phase II study of topotecan and bevacizumab in advanced refractory non-small cell lung cancer (NSCLC).
    Powell, S. F.
    Beitinjaneh, A.
    Bliss, R. L.
    Kratzke, R. A.
    Leach, J. W.
    Dudek, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [50] A phase II and pharmacogenomic study of Irinotecan and carboplatin in advanced non-small cell lung cancer (NSCLC).
    Pillot, GA
    Hennenfent, K
    Read, W
    Marsh, S
    McLeod, HL
    Gao, F
    Govindan, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 648S - 648S
12345